Ernexa Therapeutics (ERNAW) Amortization of Deferred Charges (2015 - 2024)
Ernexa Therapeutics (ERNAW) reported Amortization of Deferred Charges of $4.4 million for Q4 2024, up 1664.94% on a YoY basis from $251000.0 in Q1 2024, and up 949.76% quarter-over-quarter from $422000.0 in Q3 2024.
Ernexa Therapeutics (ERNAW) Amortization of Deferred Charges (2015 - 2024) Analysis & Trends
Ernexa Therapeutics has reported Amortization of Deferred Charges for 8 years, with the latest figure at $4.4 million in Q4 2024.
- For the quarter ending Q4 2024, Amortization of Deferred Charges rose 1664.94% year-over-year to $4.4 million; the trailing twelve-month figure through Dec 2024 stood at $5.8 million (up 1551.57% YoY), and the FY2024 full-year result was $5.3 million, up 1635.64% from the prior year.
- Amortization of Deferred Charges for Q4 2024 stood at $4.4 million, up from $422000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $4.4 million in Q4 2024, with the low at $2000.0 in Q4 2020.
- Historically, Amortization of Deferred Charges has averaged $769125.0 across 3 years, with a median of $336500.0 in 2023.
- Annual changes were most pronounced in 2020 — Amortization of Deferred Charges changed 0.0% — and 2024, when it surged 1664.94%.
- Ernexa Therapeutics' Amortization of Deferred Charges stood at $2000.0 in 2020, then soared by 12450.0% to $251000.0 in 2023, then surged by 1664.94% to $4.4 million in 2024.
- The last three Amortization of Deferred Charges figures came in at $4.4 million (Q4 2024), $422000.0 (Q3 2024), and $500000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ernexa Therapeutics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 4.43 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Sep 30, 2024 | 422,000.00 |
| Sep 30, 2024 | 422,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | 445,000.00 |
| Mar 31, 2024 | 445,000.00 |
| Dec 31, 2023 | 251,000.00 |
| Dec 31, 2023 | 251,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Dec 31, 2020 | 2,000.00 |
| Dec 31, 2020 | 2,000.00 |
| Mar 31, 2020 | 3,000.00 |
| Mar 31, 2020 | 3,000.00 |
| Dec 31, 2019 | 2,000.00 |
| Dec 31, 2019 | 2,000.00 |
| Sep 30, 2019 | 2,000.00 |
| Sep 30, 2019 | 2,000.00 |